A 21-year-old male was clinically diagnosed with familial hypercholesterolemia (FH) by the manifestations of hypercholesterolemia, tendon xanthoma and family history of premature coronary heart disease. Low density lipoprotein receptor gene was analyzed in attempt to determine a possible point mutation. The normal sequence waspartially preserved, and the patient was genetically diagnosed as a heterozygote of FH. In addition, screening for two cholesteryl ester transfer protein (CETP) gene mutations commonto Japanese revealed the patient to be a heterozygote of CETP deficiency. A complication of two influential mutations for atherosclerotic ailments was genetically ascertained.
Introduction
Familial hypercholesterolemia (FH) may be the most important disorder of lipid metabolism because of its high frequency and tendency to cause death due to premature coronary artery disease. High levels of plasma low density lipoprotein cholesterol (LDL-C) in FH patients are often resistant to medical treatment. To diagnose FH early and to treat patients appropriately, it is important to investigate the family of FH patients, to prevent the development of atherosclerotic ailments. With more than 150 mutations of the low density lipoprotein (LDL) receptor gene (1) , the diagnosis ofFH has oftenbeen made from clinical manifestations : hypercholesterolemia, tendon xanthoma and a family history of premature coronary heart disease. It is also important to determine particular genetic disorders related to FH to establish FH in other family members.
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Cholesteryl
ester transfer protein (CETP) deficiency has almost only been identified in Koreans, Chinese, and Japanese (2, 3), and is characterized by increased high density lipoprotein cholesterol (HDL-C) levels. It is suggested that CETP deficiency may prevent atherosclerotic disease due to its high HDL-C level (4, 5) , but recent studies demonstrate atherogenic profiles of CETP deficiency in some conditions (6, 7 for point mutations with the single strand conformation polymorphism method. The single strand moiety of exon 17 from this patient migrated at a different position from the control, exhibiting amutation in exon 17 (Fig. 2) . The exon 17 sequence was compared with a control by the direct sequence method (Fig. 3) . The base sequence AAG of 790 lysine was partially altered to TAG which created a stop codon and it was confirmed to be a heterozygote ofK790X, which is a commonmutation of FH (9) . Since exon 17 constitutes the genetic code of the protein of the transmembrane site of the LDL receptor, it indicated that the moiety of the LDL receptor was lacking after this site. Screening for two CETP gene mutations common in Japanese, a missense mutation of Asp 442 to Gly in exon 15 (D442G) and a G to A mutation of the splice donor site ofintron 14 (I14A), was performed by analysis with the restriction fragment length polymorphism method. By amplifying chromosome 16 and cutting it by Msp I, which is a restriction enzyme of CETP deficiency D442G, some of the fragments exhibited 209bp and the others 246bp (Fig. 4) . This showed heterozygotes ofD442G, one of the most common mutations of CETP deficiency (10, 1 1).
The same LDL receptor gene mutation was demonstrated in the father and the same CETP gene mutation in the mother. This finding indicates inherited familial hypercholesterolemia from the father and CETP deficiency from the mother.
Discussion
Several population variances in lipoprotein levels can probably be attributed to genetic factors (12, 13) . Some facilitate atherosclerosis, and others inhibit it. Increased levels of LDL-C is the most important change in lipid metabolic disorders since it is a preventable cause of acute coronary syndrome. A number of genetic conditions have been identified that affect LDL-C levels: FH is a relatively common cause of elevated LDL-C levels and is present in about 5% of patients with myocardial infarction (14); it is an autosomaldominant disorder due to a defective LDL receptor gene on chromosome 1 9 and the incidence ofheterozygotes is about one per 500 individuals (15) . A genetic diagnosis of FH is very laborious as there are more than 150 mutations of the LDL receptor gene (1) . A large number of these mutations have already been described in Japan, and K790X is a common mutation of the LDL receptor gene, which has been reported from different parts of Japan (9, 16, 17) . The hospital has identified this mutation in seven unrelated families in Hokkaido, and identification of gene mutations is useful in determining other affected family members. Patients with heterozygous FH exhibit a striking diversity in the age at which they develop coronary artery complaints, and even patients with homozygous FH, in whom plasma cholesterol levels exceed 800 mg/dl, may differby as much as 30 years in the age at which coronary artery disease is expressed clinically (23). The concomitant genetic mutation demonstrated in the present case may help to explain such variation.
